Literature DB >> 35525881

Expanding the Database of Signal-Anchor-Release Domain Endolysins Through Metagenomics.

Marco Túlio Pardini Gontijo1, Mateus Pereira Teles2,3, Pedro Marcus Pereira Vidigal4, Marcelo Brocchi2.   

Abstract

Endolysins are bacteriophage-derived lytic enzymes with antimicrobial activity. The action of endolysins against Gram-negative bacteria remains a challenge due to the physical protection of the outer membrane. However, recent research has demonstrated that signal-anchor-release (SAR) endolysins permeate the outer membrane of Gram-negative bacteria. This study investigates 2628 putative endolysin genes identified in 183,298 bacteriophage genomes. Previously, bioinformatic approaches resulted in a database of 66 SAR endolysins. This manuscript almost doubles the list with 53 additional SAR endolysin candidates. Forty-eight of the putative SAR endolysins described in this study contained one muramidase catalytic domain, and five included additional cell wall-binding domains at the C-terminus. For the moment, SAR domains are found in four protein families: glycoside hydrolase family 19 (GH19), glycoside hydrolase family 24 (GH24), glycoside hydrolase family 25 (GH25), and glycoside hydrolase family 108 (GH108). These SAR lysis are clustered in eight groups based on biochemical properties and domain presence/absence. Therefore, in this study, we expand the arsenal of endolysin candidates that might act against Gram-negative bacteria and develop a consult database for antimicrobial proteins derived from bacteriophages.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antibiotic substitute; Antimicrobial; Bacteriophage-mediated lysis; Endolysin; Enzybiotic; Novel therapy

Mesh:

Substances:

Year:  2022        PMID: 35525881     DOI: 10.1007/s12602-022-09948-y

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  43 in total

1.  Bacteriophages that infect Gram-negative bacteria as source of signal-arrest-release motif lysins.

Authors:  Marco Túlio Pardini Gontijo; Pedro Marcus Pereira Vidigal; Maryoris Elisa Soto Lopez; Marcelo Brocchi
Journal:  Res Microbiol       Date:  2020-12-19       Impact factor: 3.992

2.  Microbiome: Getting organized early in life.

Authors:  Andrea Du Toit
Journal:  Nat Rev Microbiol       Date:  2017-02-13       Impact factor: 60.633

Review 3.  Bacteriophages and their enzymes in biofilm control.

Authors:  Benjamin K Chan; Stephen T Abedon
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 4.  Diversity of phage infection types and associated terminology: the problem with 'Lytic or lysogenic'.

Authors:  Zack Hobbs; Stephen T Abedon
Journal:  FEMS Microbiol Lett       Date:  2016-02-29       Impact factor: 2.742

5.  Cloning, Characterization, and Antibacterial Properties of Endolysin LysE Against Planktonic Cells and Biofilms of Aeromonas hydrophila.

Authors:  Pallavi Baliga; Puneeth Thadooru Goolappa; Malathi Shekar; Girisha Shivani Kallappa
Journal:  Probiotics Antimicrob Proteins       Date:  2022-01-07       Impact factor: 4.609

Review 6.  Phage lysis: three steps, three choices, one outcome.

Authors:  Ryland Young
Journal:  J Microbiol       Date:  2014-03-01       Impact factor: 3.422

Review 7.  Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.

Authors:  Nina Chanishvili
Journal:  Adv Virus Res       Date:  2012       Impact factor: 9.937

8.  A signal-arrest-release sequence mediates export and control of the phage P1 endolysin.

Authors:  Min Xu; Douglas K Struck; John Deaton; Ing-Nang Wang; Ry Young
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-16       Impact factor: 11.205

Review 9.  Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.

Authors:  Derek M Lin; Britt Koskella; Henry C Lin
Journal:  World J Gastrointest Pharmacol Ther       Date:  2017-08-06

Review 10.  Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis.

Authors:  Susanna Esposito; Guido Pennoni; Valeria Mencarini; Nicola Palladino; Laura Peccini; Nicola Principi
Journal:  Front Pharmacol       Date:  2019-08-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.